News

2021.10.11

news The Cyclic Innovation for Clinical Empowerment (CiCLE) project of the Japan Agency for Medical Research and Development decided to continue supporting our clinical trial.

2021.10.04

news Our listing on the Tokyo Stock Exchange Mothers market and an article on the PAI-1 inhibitor RS5614 (for CML, COVID-19, etc.) were featured in The Chemical Daily.

2021.09.27

news Kahoku Shimpo featured our listing on the Tokyo Stock Exchange Mothers market as a Tohoku University venture.

2021.09.24

news Renascience announces the closing of its initial public offering on the Tokyo Stock Exchange Mothers market

2021.09.02

news Our efforts for the medical application of artificial intelligence (AI) (hemodialysis, respiratory diagnosis, etc.) were featured in Nikkei Biotechnology and Business

2021.08.18

news Notice Regarding Approval of Listing on the Tokyo Stock Exchange Mothers Market

2021.07.19

news Nikkei Sangyo Shimbun featured our work on AI project

2021.07.06

news Development of a swallowing function evaluation system using artificial intelligence was featured in the Chemical Daily.

2021.06.25

news Collaboration agreement with Nipro Corporation on chronic dialysis system support was featured in the morning edition of Nihon Keizai Shimbun

2021.06.25

news Collaboration Agreement with Nipro Corporation for the Development of Chronic Dialysis Support System.